Localized and Disseminated Histiocytic Sarcoma of Dendritic Cell Origin in Dogs
Top Cited Papers
Open Access
- 1 January 2002
- journal article
- research article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 39 (1), 74-83
- https://doi.org/10.1354/vp.39-1-74
Abstract
Canine histiocytic proliferative disorders include a wide spectrum of diseases characterized by different biologic behaviors. The etiology and pathogenesis of these diseases are largely unknown. The clinicopathologic, morphologic and immunophenotypic characteristics of canine localized and disseminated histiocytic sarcoma were examined in 39 dogs. Rottweilers, Bernese Mountain Dogs, and retrievers were most commonly affected (79%). Localized histiocytic sarcomas (19 dogs) arose from a single site, and metastatic lesions were observed in draining lymph nodes. Predilection sites were subcutis and underlying tissues on extremities, but tumors occurred in other locations, including spleen, lung, brain, nasal cavity, and bone marrow. Disseminated histiocytic sarcomas (20 dogs), a multisystem disease previously described as malignant histiocytosis, primarily affected spleen, lungs, bone marrow, liver, and lymph nodes. Both localized and disseminated canine histiocytic sarcomas were composed of pleomorphic tumor cell populations. CD1+, CD4-, CD11c+, CD11d-, MHC II+, ICAM-1+, Thy-1± tumor cells were identified in all snap-frozen samples (31 dogs). This phenotype is characteristic for myeloid dendritic antigen-presenting cell lineage. Hence, canine localized and disseminated histiocytic sarcomas are likely myeloid dendritic cell sarcomas. Dendritic antigen-presenting cells are a heterogeneous cell population with regards to their ontogeny, phenotype, function, and localization. The exact sublineage of the proliferating dendritic antigen-presenting cells involved in canine histiocytic sarcomas remains to be determined. Phenotypic analysis of formalin-fixed tissues from eight dogs was limited by available markers. Morphologic features and the phenotype CD18+, CD3-, and CD79a- were the most useful criteria to indicate likely histiocytic origin.Keywords
This publication has 37 references indexed in Scilit:
- Canine Cutaneous and Systemic HistiocytosisThe American Journal of Dermatopathology, 2000
- MALIGNANT HISTIOCYTIC DISORDERS IN CHILDREN: Clinical and Therapeutic Approaches with a Nosologic DiscussionHematology/Oncology Clinics of North America, 1998
- Contemporary classification of histiocytic disordersMedical and Pediatric Oncology, 1997
- CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.The Journal of Experimental Medicine, 1996
- Malignant histiocytosis: A reassessment of cases formerly classified as histiocytic neoplasms and review of the literatureMedical and Pediatric Oncology, 1995
- Epitope Mapping of CD1a, CD1b, and CD1c Antigens in Human Skin: Differential Localization on Langerhans Cells, Keratinocytes, and Basement Membrane ZoneJournal of Investigative Dermatology, 1992
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- The CD1 systemTissue Antigens, 1991
- Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skinBritish Journal of Dermatology, 1989
- Malignant Fibrous Histiocytoma in Dogs and CatsVeterinary Pathology, 1979